CLINICAL_TRIALS
research
· 2026-03-20
Clinical Trial Update: Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors [NA]
Summary
A clinical trial evaluating circulating tumor DNA in stage I-III germ-cell tumors, currently NOT_YET_RECRUITING.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Indiana University | Conditions: Germ Cell Cancer Metastatic | NA | Status: NOT_YET_RECRUITING